These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 15562330)

  • 21. Human rhinovirus 3C protease: generation of pharmacophore models for peptidic and nonpeptidic inhibitors and their application in virtual screening.
    Steindl T; Laggner C; Langer T
    J Chem Inf Model; 2005; 45(3):716-24. PubMed ID: 15921461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Next generation chemical proteomic tools for rapid enzyme profiling.
    Uttamchandani M; Lu CH; Yao SQ
    Acc Chem Res; 2009 Aug; 42(8):1183-92. PubMed ID: 19435360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dimethylthiazolidine carboxylic acid as a rigid p3 unit in inhibitors of serine proteases: application to two targets.
    Kawai SH; Aubry N; Duceppe JS; Llinàs-Brunet M; LaPlante SR
    Chem Biol Drug Des; 2009 Nov; 74(5):517-22. PubMed ID: 19780760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
    Tsantrizos YS
    Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specificity of aza-peptide electrophile activity-based probes of caspases.
    Sexton KB; Kato D; Berger AB; Fonovic M; Verhelst SH; Bogyo M
    Cell Death Differ; 2007 Apr; 14(4):727-32. PubMed ID: 17170749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates.
    Shalaby SM; Zakora M; Otte J
    J Dairy Res; 2006 May; 73(2):178-86. PubMed ID: 16476177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of ACE-inhibitory peptides from a random peptide-displayed phage library using ACE-coupled liposomes.
    Kumada Y; Hashimoto N; Hasan F; Terashima M; Nakanishi K; Jungbauer A; Katoh S
    J Biotechnol; 2007 Aug; 131(2):144-9. PubMed ID: 17658644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells.
    Laggner H; Hermann M; Esterbauer H; Muellner MK; Exner M; Gmeiner BM; Kapiotis S
    J Hypertens; 2007 Oct; 25(10):2100-4. PubMed ID: 17885553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin I-converting enzyme inhibitory activity in spontaneously hypertensive rats.
    Li GH; Qu MR; Wan JZ; You JM
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():275-80. PubMed ID: 17392118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of bee venom on protease activities and free radical damages in synovial fluid from type II collagen-induced rheumatoid arthritis rats.
    Suh SJ; Kim KS; Kim MJ; Chang YC; Lee SD; Kim MS; Kwon DY; Kim CH
    Toxicol In Vitro; 2006 Dec; 20(8):1465-71. PubMed ID: 16989977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid-phase synthesis and pharmacological evaluation of a library of peptidomimetics as potential farnesyltransferase inhibitors: an approach to new lead compounds.
    Gilleron P; Millet R; Houssin R; Wlodarczyk N; Farce A; Lemoine A; Goossens JF; Chavatte P; Pommery N; Hénichart JP
    Eur J Med Chem; 2006 Jun; 41(6):745-55. PubMed ID: 16647166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [VI Symposium on "Chemistry of Proteolytic Enzymes"].
    Rumsh LD; Rotanova TV
    Bioorg Khim; 2008; 34(3):293-4. PubMed ID: 18672674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of bacterial proteases with a panel of fluorescent peptide substrates.
    Wildeboer D; Jeganathan F; Price RG; Abuknesha RA
    Anal Biochem; 2009 Jan; 384(2):321-8. PubMed ID: 18957278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of varying chain length between P(1) and P(1') position of tripeptidomimics on activity of angiotensin-converting enzyme inhibitors.
    Chaudhary S; Vats ID; Chopra M; Biswas P; Pasha S
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4364-6. PubMed ID: 19523823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Protease Inhibitors.
    Norman P
    Drug News Perspect; 2002 Jul; 15(6):372-382. PubMed ID: 12677235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.